Frontiers In Immunology

dc.creatorIbáñez-Irribarra, Francisco J
dc.creatorFarias, Mónica Andréa
dc.creatorRetamal-Díaz, Angello Ricardo
dc.creatorEspinoza, Janyra A
dc.creatorKalergis, Alexis M
dc.creatorGonzález-Muñoz, Pablo Alberto
dc.date2018-10-01T16:02:10Z
dc.date2022-07-07T15:17:07Z
dc.date2018-10-01T16:02:10Z
dc.date2022-07-07T15:17:07Z
dc.date2017
dc.date.accessioned2023-08-22T23:11:59Z
dc.date.available2023-08-22T23:11:59Z
dc.identifier1140011
dc.identifier1140011
dc.identifierhttps://hdl.handle.net/10533/220723
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8350138
dc.descriptionHeme oxygenase-1 (HO-1) is an inducible enzyme that is expressed in response to physical and chemical stresses, such as ultraviolet radiation, hyperthermia, hypoxia, reactive oxygen species (ROS), as well as cytokines, among others. Its activity can be positively modulated by cobalt protoporphyrin (CoPP) and negatively by tin protoporphirin (SnPP). Once induced, HO-1 degrades iron-containing heme into ferrous iron (Fe2+), carbon monoxide (CO) and biliverdin. Importantly, numerous products of HO-1 are cytoprotective with anti-apoptotic, anti-oxidant, anti-inflammatory, and anti-cancer effects. The products of HO-1 also display antiviral properties against several viruses, such as the human immunodeficiency virus (HIV), influenza, hepatitis B, hepatitis C, and Ebola virus. Here, we sought to assess the effect of modulating HO-1 activity over herpes simplex virus type 2 (HSV-2) infection in epithelial cells and neurons. There are no vaccines against HSV-2 and treatment options are scarce in the immunosuppressed, in which drug-resistant variants emerge. By using HSV strains that encode structural and non-structural forms of the green fluorescent protein (GFP), we found that pharmacological induction of HO-1 activity with CoPP significantly decreases virus plaque formation and the expression of virus-encoded genes in epithelial cells as determined by flow cytometry and western blot assays. CoPP treatment did not affect virus binding to the cell surface or entry into the cytoplasm, but rather downstream events in the virus infection cycle. Furthermore, we observed that treating cells with a CO-releasing molecule (CORM-2) recapitulated some of the anti-HSV effects elicited by CoPP. Taken together, these findings indicate that HO-1 activity interferes with the replication cycle of HSV and that its antiviral effects can be recapitulated by CO. Keywords. Author Keywords:heme oxygenase-1; carbon monoxide; pharmacological induction; antiviral drug; herpes simplex virus; capsid
dc.languageeng
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.relationinfo:eu-repo/grantAgreement//1140011
dc.relationinfo:eu-repo/semantics/dataset/hdl.handle.net/10533/93477
dc.relationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671570/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.titlePharmacological Induction of Heme Oxygenase-1 Impairs Nuclear Accumulation of Herpes Simplex Virus Capsids upon Infection
dc.titleFrontiers In Immunology
dc.typeArticulo
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución